Department of Cardiothoracic and Vascular Surgery, 422637All India Institute of Medical Sciences, New Delhi, India.
Department of Pediatric Cardiac Sciences, 78363Sir Ganga Ram Hospital, New Delhi, India.
World J Pediatr Congenit Heart Surg. 2020 Sep;11(5):572-577. doi: 10.1177/2150135120935418.
Hepatic derangements and liver injury following the Fontan operation (FO) may progress in some cases to hepatic fibrosis (HF) and cirrhosis. The respective roles of transient elastography (TE) or FibroScan, shear wave elastography (SWE), and aspartate transaminase to platelet ratio index (APRI) in assessing liver stiffness (LS) and possible liver injury in these patients are unclear.
Thirty-nine patients (31 males), mean age 11.8 ± 5.7 years, median 11 years (interquartile range: 7-14.7 years), undergoing the FO between November 2017 and December 2018 were included. Liver stiffness and HF assessment was done with TE, SWE, and APRI in the preoperative period and postoperatively at 3-, 6-, and 12-month interval.
The LS values increased over time (postoperative values at 3, 6, and 12 months) as compared to preoperative values by both FibroScan and SWE. The change in liver stiffness measurement (LSM) was statistically significant: LSM0 to LSM3 ( ≤ .0001), LSM0 to LSM6 ( ≤ .0001), and LSM0 to LSM12 ( = .001). Similarly, significant changes were observed on SWE: SWE0 to SWE3 ( ≤ .0001), SWE0 to SWE6 ( ≤ .0001), and SWE0 to SWE12 ( = .001). There was no significant change in the APRI values over time.
Noninvasive methods such as FibroScan and SWE may be of use to assess LS in follow-up of patients undergoing the FO for early recognition of hepatic changes.
Fontan 手术后(FO)肝脏功能障碍和肝损伤可能在某些情况下进展为肝纤维化(HF)和肝硬化。瞬时弹性成像(TE)或 FibroScan、剪切波弹性成像(SWE)以及天门冬氨酸转氨酶血小板比值指数(APRI)在评估这些患者的肝硬度(LS)和可能的肝损伤方面的各自作用尚不清楚。
39 名患者(31 名男性),平均年龄 11.8 ± 5.7 岁,中位数 11 岁(四分位距:7-14.7 岁),于 2017 年 11 月至 2018 年 12 月期间接受 FO。在术前和术后 3、6 和 12 个月的间隔期内,通过 TE、SWE 和 APRI 评估肝硬度和 HF。
与术前相比,术后 FibroScan 和 SWE 的 LS 值随时间增加(术后 3、6 和 12 个月)。肝硬度测量(LSM)的变化具有统计学意义:LSM0 至 LSM3(≤.0001),LSM0 至 LSM6(≤.0001),LSM0 至 LSM12(=.001)。同样,在 SWE 上也观察到显著变化:SWE0 至 SWE3(≤.0001),SWE0 至 SWE6(≤.0001),SWE0 至 SWE12(=.001)。APRI 值随时间无显著变化。
非侵入性方法,如 FibroScan 和 SWE,可用于评估 FO 后患者的 LS,以便早期识别肝变化。